PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsunstable angina
MeSH D000789 - unstable angina
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000787:Angina pectoris
148 Companies
27 Drugs
$
Success rate
D000789: 
Unstable angina
55 Companies
13 Drugs
$
Success rate
D000788:Variant angina pectoris
101 Companies
20 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
50%
5/10
Phase 3
78%
21/27
Approved: 10Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Johnson & Johnson
Abciximab,
Serine,
Thienopyridine
GSK
Fondaparinux sodium,
Eptifibatide,
Fondaparinux,
Wellbutrin
Aspen Global
Heparin,
Heparin sodium
Novartis
Dihydroergotamine,
Heparin,
Heparin sodium,
Lidocaine
Sanofi
Heparin,
Enoxaparin sodium,
Enoxaparin,
Heparin sodium,
Otamixaban,
Ancrod,
Serine,
Sr123781a
Merck & Co
Eptifibatide
Pfizer
Heparin,
Dalteparin,
Heparin sodium,
Dalteparin sodium,
Insulin,
Viaject
Eli Lilly
Heparin,
Heparin sodium
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use